Skip to content
Innovative Tech
Diseases
Health Policy
HTA
Data Analysis
Clinical Practice
Contributors
BACK TO MAIN SITE
The Role of Real-World Evidence in CMS Price Ne...
By
Melike Belenli Gümüş
June 28, 2024
Introduction The role of real-world evidence (RWE) in the
Enhancing Global Health through Cost-Effectiveness Analysis
The Role of Pull Incentives in Addressing Antimicrobial Resistance
A Cost-Saving Life-Saver: The Impact of Palivizumab in Columbia
Tuberculosis Care in Indonesia: A Financial Analysis of Strategic Purchasing ...
Cost-Effectiveness of IDegAsp in Diabetes Management: Insights from ARISE Study
Understanding the Cost and Clinical Impact of Multisystem Inflammatory Syndro...
Striking the Balance: Optimising Hepatitis B Treatment Strategies in The Gambia
Cost-Utility and Cost-Effectiveness of Disease-Modifying Drugs for Relapsing-...
The Economic Benefits of Preventive Health Programs
The Shift to Value-Based Drug Pricing in the United States
Cost Savings on Generic Drugs: Transparent Pricing Models
Brucellosis Control in Armenia: A Holistic Approach
« Previous
1
…
21
22
23
24
25
…
43
Next »